Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance / Moon, Hs; Matarese, Giuseppe; Brennan, Am; Chamberland, Jp; Liu, X; Fiorenza, Cg; Mylvaganam, Gh; Abanni, L; Carbone, F; Williams, Cj; De Paoli, Am; Schneider, Be; Mantzoros, Cs. - In: DIABETES. - ISSN 0012-1797. - 60:(2011), pp. 1647-1656. [10.2337/db10-1791]

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.

MATARESE, GIUSEPPE;
2011

2011
Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance / Moon, Hs; Matarese, Giuseppe; Brennan, Am; Chamberland, Jp; Liu, X; Fiorenza, Cg; Mylvaganam, Gh; Abanni, L; Carbone, F; Williams, Cj; De Paoli, Am; Schneider, Be; Mantzoros, Cs. - In: DIABETES. - ISSN 0012-1797. - 60:(2011), pp. 1647-1656. [10.2337/db10-1791]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/622035
Citazioni
  • ???jsp.display-item.citation.pmc??? 64
  • Scopus 114
  • ???jsp.display-item.citation.isi??? 110
social impact